Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-03-20

Clinical Trial Update: A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation [NA]

View source ↗

Summary

A prospective multi-centre trial evaluating bipolar radiofrequency ablation for atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Atrial Fibrillation | NA | Status: WITHDRAWN